Austin, Texas — 04/02/2019 — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy-to-use products for complex testing in genetics and oncology, today announced a substantial
The Horizon ® system was designed to offer more versatility in one system, and more treatment options for patients.  This clearance allows Magstim to market the 3-minute
Seattle, WA, March 28, 2019 – RareCyte® announces the CyteFinder® II and CyteFinder II HT Instruments in conjunction with the American Association for Cancer Research Annual Meeting
March 20, 2019 – Guilford, CT/Walnut Creek, CA – Medpricer, the leading purchased services cost management solution for the healthcare industry, announced today the launch of
Cardiff, UK, and Baltimore, U.S., January 29, 2018 – TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, and
MENLO PARK–(BUSINESS WIRE)—October 31, 2018—Akoya Biosciences (Akoya), a Telegraph Hill Partners (THP) company, has acquired PerkinElmer, Inc’s Quantitative Pathology Solutions (QPS) portfolio.  Akoya was founded
SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has
The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Texas — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to
Carlsbad, CA, 07/11/18– Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a
First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business Salt Lake City, UT, USA and
Seattle, WA, April 16, 2018 – RareCyte, Inc., a global rare cell detection and liquid biopsy company announces its newest product, CyteFinder HT in conjunction
SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today